Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

NCT00002790 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: cyclosporine
DRUG: methotrexate
DRUG: sirolimus

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]